Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Log inSign up
Challenges
Datasets
Workspaces
Papers
Discussions
Leaderboard
Blog
Job Board
Q3AS

© 2026 Aqora Quantum S.A.S.

TermsPrivacyLegal Notice

Panhellenic Conference on Informatics

Quantum Machine Learning in Drug Discovery: Current State and Challenges

Maria Avramouli, Ilias Κ. Savvas, Anna Vasilaki, Georgia Garani, Apostolos Xenakis

Published Nov 25, 2022• 13 citations
Publisher

Abstract

The drug discovery process is a time-consuming and quite expensive process. The predictive models of machine learning algorithms have been used efficiently for years in various stages of the drug discovery pipeline. The complexity of these algorithms increases as the size of the molecule increases, adding a single atom to a molecule increases the number of possible combinations. Quantum computers with quantum supremacy can play an important role in complex calculations. Combining the two technologies in practice is a complex endeavor that requires diverse, interdisciplinary teams of scientists working together to be able to integrate the two technologies with the goal of reducing cost and time in drug discovery.

DOI
10.1145/3575879.3576024

Related papers

Quantum Machine Learning for Drug Discovery: Taxonomy, Research Challenges, and the Road Ahead

Yen H. P. Duong, Syed Muhammad Abuzar Rizvi, B. D. E. McNiven +4 more

The recent pandemic outbreak has posed significant challenges for medical research, particularly in drug discovery. Machine learning (ML) has become increasingly prevalent in various stages of drug discovery, aiming to support the advancement of new drug research while reducing time and cost investments. Furthermore, the emergence of quantum computing and quantum machine learning (QML) represents a significant advancement in this field, offering the ability to tackle the complex processes involved in drug discovery. This review provides a comprehensive perspective, comparing advanced QML to classical ML in drug discovery applications including drug design, virtual screening, and absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction. Additionally, we summarize the current applications of QML algorithms to real-world datasets utilized in clinical research and drug discovery.

ACM Computing Surveys•Dec 22, 2025•1 citation

Quantum-Machine-Assisted Drug Discovery: Survey and Perspective

Yidong Zhou, Gopal Karemore, Weikang Li +5 more

Drug discovery and development is a highly complex and costly endeavor, typically requiring over a decade and substantial financial investment to bring a new drug to market. Traditional computer-aided drug design (CADD) has made significant progress in accelerating this process, but the development of quantum computing offers potential due to its unique capabilities. This paper discusses the integration of quantum computing into drug discovery and development, focusing on how quantum technologies might accelerate and enhance various stages of the drug development cycle. Specifically, we explore the application of quantum computing in addressing challenges related to drug discovery, such as molecular simulation and the prediction of drug-target interactions, as well as the optimization of clinical trial outcomes. By leveraging the inherent capabilities of quantum computing, we might be able to reduce the time and cost associated with bringing new drugs to market, ultimately benefiting public health.

•Aug 27, 2024•8 citations

Unlocking the Potential of Quantum Machine Learning to Advance Drug Discovery

Maria Avramouli, Ilias Κ. Savvas, Anna Vasilaki +1 more

The drug discovery process is a rigorous and time-consuming endeavor, typically requiring several years of extensive research and development. Although classical machine learning (ML) has proven successful in this field, its computational demands in terms of speed and resources are significant. In recent years, researchers have sought to explore the potential benefits of quantum computing (QC) in the context of ML, leading to the emergence of Quantum Machine Learning (QML) as a distinct research field. The objective of the current study is twofold: first, to present a review of the proposed QML algorithms for application in the drug discovery pipeline, and second, to compare QML algorithms with their classical and hybrid counterparts in terms of their efficiency. A query-based search of various databases took place, and five different categories of algorithms were identified in which QML was implemented. The majority of QML applications in drug discovery are primarily focused on the initial stages of the drug discovery pipeline, particularly with regard to the identification of novel drug-like molecules. Comparison results revealed that QML algorithms are strong rivals against the classical ones and a hybrid solution is the recommended approach at present.

Electronics•May 25, 2023•42 citations

Quantum Computing in Drug Discovery

Bancha Yingngam, Alex Khang

The drug discovery process necessitates a significant investment of time and resources. Typically, over a decade and billions of dollars are required to bring a single drug to market. However, quantum computing may provide a solution to these challenges. It not only has the potential to streamline drug discovery but also to enhance the quality and accuracy of the results. This chapter explores the innovative amalgamation of quantum computing and pharmaceutical research. Traditional drug discovery methods, due to their time-consuming and costly nature, face numerous obstacles. Quantum computing, armed with its extraordinary computational power, could surmount these hurdles by providing efficient and precise simulations of drug molecules. This could, in turn, expedite the discovery of effective drug candidates. The chapter delves into the fundamentals of quantum computing, its application in drug discovery, and specific techniques relevant to this field. It also presents case studies of successful applications and discusses prospects, taking current limitations into account. A particularly exciting development in this field is quantum machine learning, a fusion of quantum mechanics and machine learning. This synergy could accelerate scientific advances by offering robust predictive modeling for drug discovery. Consequently, this chapter provides an in-depth exploration of a potential future in which quantum technology, artificial intelligence, and robotics are fully integrated. Such integration could revolutionize drug discovery, heralding a new era in health care and reshaping the boundaries of medical science and therapeutic development.

CRC Press eBooks•Aug 2, 2024•5 citations

Quantum Machine Learning for Drug Discovery: A Systematic Review

Anisurrahman, Bashir Alam, Muhammad Hamid

Quantum computing plays a significant role in simulating molecules and atoms and offers advantages in chemistry over classical computing. The potential of Quantum Machine Learning (QML) can be used in drug discovery, chemical reaction simulations, and Material design for pharmaceuticals. QML leverages quantum computing and advanced machine learning to accelerate the identification of drug candidates, predict molecular interactions, and optimize compounds. In this paper, we present a systematic review of the methods used for molecular property prediction and molecular generation using quantum machine learning. We have included the recent research, perspective, advantages, and challenges that must be addressed to achieve this task. The objective of this research is not only to discuss current strategies and methods used for drug discovery but also to promote interdisciplinary research in the field of quantum computing and chemistry for wellness.

International Journal on Smart & Sustainable Intelligent Computing•Jun 30, 2025•0 citations

Quantum Computing in Drug Discovery: A Review of Foundations and Emerging Applications

Pushpalata Patil, Ravindra D Patil, Sandeep Kulkarni

Research Problem: The traditional methods of drug discovery are time-consuming, costly, and at times ineffective. There is a need for more novel approaches that can enhance the processes of discovering new drugs and developing them into usable products. Objective of the Paper: This paper aims to conduct a review of the literature and find how the application of quantum computing can change the way drugs are discovered and processed in practice. Process of Review: The review process involved a comprehensive examination of the available literature and recent advances in the application of quantum computing to drug discovery. The review encompassed major studies, theories, and case studies related to the subject matter, aiming to identify the current state and potential future directions of the domain. Insights of the Review: 1. Primary Building Blocks: With quantum computing, superposition, entanglement, and other principles can be utilised to enable complex computations to be performed at higher speeds using less time than traditional computers. 2. Quantum modelling: Quantum computers are expected to accurately model the interactions of various molecules, which could result in the identification of viable drug candidates. 3. Drug Discovery Processes: Quantum algorithms are capable of faster processing than traditional methods when it comes to solving optimisation problems, such as protein structure prediction and molecular docking, in drug design. 4. Limitations and Challenges: As great as the promise of quantum computing is, it has its limitations and challenges, including hardware limitations, error rates, and the need for specialised algorithms. 5. Future Developments: The ongoing development of quantum hardware and algorithms is expected to enhance the practical applications of quantum computing in drug discovery, enabling the quicker and more cost-effective creation of new drugs.

International Journal of Advanced Pharmaceutical Sciences and Research•Jun 27, 2025•0 citations
The drug discovery process is a time-consuming and quite expensive process. The predictive models of machine learning algorithms have been used efficiently for years in various stages of the drug discovery pipeline. The complexity of these algorithms increases as the size of the molecule increases, adding a single atom to a molecule increases the number of possible combinations. Quantum computers with quantum supremacy can play an important role in complex calculations. Combining the two technologies in practice is a complex endeavor that requires diverse, interdisciplinary teams of scientists working together to be able to integrate the two technologies with the goal of reducing cost and time in drug discovery.
The recent pandemic outbreak has posed significant challenges for medical research, particularly in drug discovery. Machine learning (ML) has become increasingly prevalent in various stages of drug discovery, aiming to support the advancement of new drug research while reducing time and cost investments. Furthermore, the emergence of quantum computing and quantum machine learning (QML) represents a significant advancement in this field, offering the ability to tackle the complex processes involved in drug discovery. This review provides a comprehensive perspective, comparing advanced QML to classical ML in drug discovery applications including drug design, virtual screening, and absorption, distribution, metabolism, excretion and toxicity (ADMET) prediction. Additionally, we summarize the current applications of QML algorithms to real-world datasets utilized in clinical research and drug discovery.
Drug discovery and development is a highly complex and costly endeavor, typically requiring over a decade and substantial financial investment to bring a new drug to market. Traditional computer-aided drug design (CADD) has made significant progress in accelerating this process, but the development of quantum computing offers potential due to its unique capabilities. This paper discusses the integration of quantum computing into drug discovery and development, focusing on how quantum technologies might accelerate and enhance various stages of the drug development cycle. Specifically, we explore the application of quantum computing in addressing challenges related to drug discovery, such as molecular simulation and the prediction of drug-target interactions, as well as the optimization of clinical trial outcomes. By leveraging the inherent capabilities of quantum computing, we might be able to reduce the time and cost associated with bringing new drugs to market, ultimately benefiting public health.
The drug discovery process is a rigorous and time-consuming endeavor, typically requiring several years of extensive research and development. Although classical machine learning (ML) has proven successful in this field, its computational demands in terms of speed and resources are significant. In recent years, researchers have sought to explore the potential benefits of quantum computing (QC) in the context of ML, leading to the emergence of Quantum Machine Learning (QML) as a distinct research field. The objective of the current study is twofold: first, to present a review of the proposed QML algorithms for application in the drug discovery pipeline, and second, to compare QML algorithms with their classical and hybrid counterparts in terms of their efficiency. A query-based search of various databases took place, and five different categories of algorithms were identified in which QML was implemented. The majority of QML applications in drug discovery are primarily focused on the initial stages of the drug discovery pipeline, particularly with regard to the identification of novel drug-like molecules. Comparison results revealed that QML algorithms are strong rivals against the classical ones and a hybrid solution is the recommended approach at present.
The drug discovery process necessitates a significant investment of time and resources. Typically, over a decade and billions of dollars are required to bring a single drug to market. However, quantum computing may provide a solution to these challenges. It not only has the potential to streamline drug discovery but also to enhance the quality and accuracy of the results. This chapter explores the innovative amalgamation of quantum computing and pharmaceutical research. Traditional drug discovery methods, due to their time-consuming and costly nature, face numerous obstacles. Quantum computing, armed with its extraordinary computational power, could surmount these hurdles by providing efficient and precise simulations of drug molecules. This could, in turn, expedite the discovery of effective drug candidates. The chapter delves into the fundamentals of quantum computing, its application in drug discovery, and specific techniques relevant to this field. It also presents case studies of successful applications and discusses prospects, taking current limitations into account. A particularly exciting development in this field is quantum machine learning, a fusion of quantum mechanics and machine learning. This synergy could accelerate scientific advances by offering robust predictive modeling for drug discovery. Consequently, this chapter provides an in-depth exploration of a potential future in which quantum technology, artificial intelligence, and robotics are fully integrated. Such integration could revolutionize drug discovery, heralding a new era in health care and reshaping the boundaries of medical science and therapeutic development.
Quantum computing plays a significant role in simulating molecules and atoms and offers advantages in chemistry over classical computing. The potential of Quantum Machine Learning (QML) can be used in drug discovery, chemical reaction simulations, and Material design for pharmaceuticals. QML leverages quantum computing and advanced machine learning to accelerate the identification of drug candidates, predict molecular interactions, and optimize compounds. In this paper, we present a systematic review of the methods used for molecular property prediction and molecular generation using quantum machine learning. We have included the recent research, perspective, advantages, and challenges that must be addressed to achieve this task. The objective of this research is not only to discuss current strategies and methods used for drug discovery but also to promote interdisciplinary research in the field of quantum computing and chemistry for wellness.
Research Problem: The traditional methods of drug discovery are time-consuming, costly, and at times ineffective. There is a need for more novel approaches that can enhance the processes of discovering new drugs and developing them into usable products. Objective of the Paper: This paper aims to conduct a review of the literature and find how the application of quantum computing can change the way drugs are discovered and processed in practice. Process of Review: The review process involved a comprehensive examination of the available literature and recent advances in the application of quantum computing to drug discovery. The review encompassed major studies, theories, and case studies related to the subject matter, aiming to identify the current state and potential future directions of the domain. Insights of the Review: 1. Primary Building Blocks: With quantum computing, superposition, entanglement, and other principles can be utilised to enable complex computations to be performed at higher speeds using less time than traditional computers. 2. Quantum modelling: Quantum computers are expected to accurately model the interactions of various molecules, which could result in the identification of viable drug candidates. 3. Drug Discovery Processes: Quantum algorithms are capable of faster processing than traditional methods when it comes to solving optimisation problems, such as protein structure prediction and molecular docking, in drug design. 4. Limitations and Challenges: As great as the promise of quantum computing is, it has its limitations and challenges, including hardware limitations, error rates, and the need for specialised algorithms. 5. Future Developments: The ongoing development of quantum hardware and algorithms is expected to enhance the practical applications of quantum computing in drug discovery, enabling the quicker and more cost-effective creation of new drugs.